Bristol-Myers Squibb Company
Stock Forecast, Prediction & Price Target

Bristol-Myers Squibb Company (BMY) stock Price Target by analysts

Last Year
Average Price Target

$55.33

Potential upside: 14.46%

Based on 2 analysts

Bristol-Myers Squibb Company price prediction

Strike.market

What is Bristol-Myers Squibb Company stock analysts` prediction?

Bristol-Myers Squibb Company stock forecast: Based on 2 Wall Street analysts` predicted price targets for Bristol-Myers Squibb Company in the last 3 months, the avarage price target is $55.33, with a high forecast of $NaN. The average price target represents a 14.46% change from the last price of $48.34.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Bristol-Myers Squibb Company stock Price Target by analysts

Full breakdown of analysts given Bristol-Myers Squibb Company price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Evan Seigerman
BMO Capital
0%
0/4
10 months ago $61 26.18% upside $56.23 TheFly
Previous targets (3)
Evan David Seigerman
BMO Capital
33.33%
1/3
10 months ago $57 17.91% upside $54.32 StreetInsider
Previous targets (2)
Evan David Seigerman
BMO Capital
33.33%
1/3
12 months ago $48 -0.70% downside $49.56 StreetInsider
Previous targets (2)
Carter Gould
Barclays
50%
1/2
about 1 year ago $41 -15.18% downside $50.45 TheFly
Previous targets (1)
Chris Shibutani
Goldman Sachs
0%
0/1
about 1 year ago $57 17.91% upside $50.55 StreetInsider
Previous targets (0)
Trung Huynh
UBS
0%
0/1
about 1 year ago $43 -11.04% downside $40.68 TheFly
Previous targets (0)
Steve Scala
Cowen & Co.
0%
0/1
over 1 year ago $67 38.60% upside $44.11 StreetInsider
Previous targets (0)
James Shin
Deutsche Bank
0%
0/1
over 1 year ago $55 13.77% upside $49.87 Benzinga
Previous targets (0)
Evan Seigerman
BMO Capital
0%
0/4
almost 2 years ago $60 24.12% upside $49.76 Benzinga
Previous targets (3)
David Risinger
Leerink Partners
0%
0/1
almost 2 years ago $66 36.53% upside $56.25 Benzinga
Previous targets (0)
Louise Chen
Cantor Fitzgerald
0%
0/1
almost 2 years ago $75 55.15% upside $59.67 Benzinga
Previous targets (0)
Mohit Bansal
Wells Fargo
100%
1/1
over 3 years ago $70 44.80% upside $78.22 Pulse 2.0
Previous targets (0)
Unknown
Barclays
N/A
over 3 years ago $68 40.67% upside $75.27 Benzinga
N/A
Seamus Fernandez
Guggenheim
50%
1/2
over 3 years ago $80 65.49% upside $75.27 TheFly
Previous targets (1)
Evan Seigerman
BMO Capital
0%
0/4
over 3 years ago $87 79.97% upside $75.08 TipRanks Contributor
Previous targets (3)
Unknown
BMO Capital
N/A
over 3 years ago $92 90.31% upside $75.66 Benzinga
N/A
Terence Flynn
Morgan Stanley
100%
1/1
over 3 years ago $64 32.39% upside $76.5 Pulse 2.0
Previous targets (0)
Evan Seigerman
BMO Capital
0%
0/4
over 3 years ago $81 67.56% upside $73.79 Pulse 2.0
Previous targets (3)
Matthew Harrison
Morgan Stanley
100%
1/1
over 3 years ago $66 36.53% upside $73.11 Pulse 2.0
Previous targets (0)
Evan David Seigerman
BMO Capital
33.33%
1/3
over 3 years ago $74 53.08% upside $70.52 Pulse 2.0
Previous targets (2)
Carter Gould
Barclays
50%
1/2
almost 4 years ago $66 36.53% upside $56.22 StreetInsider
Previous targets (1)
Andrew Baum
Citigroup
100%
1/1
almost 4 years ago $75 55.15% upside $56.89 TheFly
Previous targets (0)
Seamus Fernandez
Guggenheim
50%
1/2
almost 4 years ago $82 69.63% upside $59.05 StreetInsider
Previous targets (1)
Justin Smith
Societe Generale
0%
0/1
almost 4 years ago $85 75.83% upside $63.63 StreetInsider
Previous targets (0)
Geoff Meacham
Bank of America Securities
100%
1/1
about 4 years ago $78 61.35% upside $65.88 TipRanks
Previous targets (0)

Bristol-Myers Squibb Company Financial Estimates

Bristol-Myers Squibb Company Revenue Estimates

Bristol-Myers Squibb Company EBITDA Estimates

Bristol-Myers Squibb Company Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$46.38B
 
N/A
$46.15B
 
-0.48%
$45.00B
 
-2.49%
Avg: $46.05B
Low: $44.96B
High: $47.39B
avg. 2.33%
Avg: $43.87B
Low: $42.52B
High: $44.98B
avg. -4.73%
Avg: $44.77B
Low: $43.40B
High: $45.91B
avg. 2.05%
Avg: $41.49B
Low: $40.22B
High: $42.55B
avg. -7.32%
Net Income
 
% change YoY
$6.99B
 
N/A
$6.32B
 
-9.53%
$8.02B
 
26.83%
Avg: $10.22B
Low: $5.73B
High: $13.90B
avg. 27.35%
Avg: $10.15B
Low: $5.63B
High: $13.83B
avg. -0.65%
Avg: $13.65B
Low: $13.10B
High: $14.10B
avg. 34.47%
Avg: $12.75B
Low: $12.24B
High: $13.17B
avg. -6.55%
EBITDA
 
% change YoY
$20.18B
 
N/A
$19.92B
 
-1.28%
$19.36B
 
-2.79%
Avg: $17.44B
Low: $17.03B
High: $17.95B
avg. -9.92%
Avg: $16.61B
Low: $16.10B
High: $17.03B
avg. -4.73%
Avg: $16.95B
Low: $16.43B
High: $17.38B
avg. 2.05%
Avg: $15.71B
Low: $15.23B
High: $16.11B
avg. -7.32%
EPS
 
% change YoY
$3.15
 
N/A
$2.97
 
-5.71%
$3.88
 
30.63%
Avg: $5.29
Low: $2.76
High: $6.69
avg. 36.24%
Avg: $5.41
Low: $2.71
High: $6.66
avg. 2.29%
Avg: $6.57
Low: $6.31
High: $6.79
avg. 21.51%
Avg: $6.14
Low: $5.89
High: $6.34
avg. -6.55%
Operating Expenses
 
% change YoY
$27.90B
 
N/A
$26.91B
 
-3.54%
$34.31B
 
27.47%
Avg: $8.05B
Low: $7.86B
High: $8.28B
avg. -76.52%
Avg: $7.67B
Low: $7.43B
High: $7.86B
avg. -4.73%
Avg: $7.82B
Low: $7.58B
High: $8.02B
avg. 2.05%
Avg: $7.25B
Low: $7.03B
High: $7.44B
avg. -7.32%

FAQ

What is Bristol-Myers Squibb Company stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 13.65% in 2025-2028.

We have gathered data from 15 analysts. Their low estimate is 5.73B, average is 10.22B and high is 13.90B.

What is Bristol-Myers Squibb Company stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of -1.91% in 2025-2028.

We have gathered data from 19 analysts. Their low revenue estimate is $44.96B, average is $46.05B and high is $47.39B.

What is Bristol-Myers Squibb Company stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 13.37% in 2025-2028.

We have gathered data from 15 analysts. Their low earnings per share estimate is $2.76, average is $5.29 and high is $6.69.

What is the best performing analyst?

In the last twelve months 2 analysts have been covering Bristol-Myers Squibb Company stock. The most successful analyst is Evan Seigerman.